PRESBIA PLC (NASDAQ:LENS) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On January22, 2018, Presbia PLC (the “Company”) and Vladimir Feingold entered into a consulting agreement by which Mr. Feingold agreed to provide consulting services to the Company and its subsidiaries through April 15, 2018 (the “Consulting Agreement”).

The Consulting Agreement, provides for, among other things, (i)an initial three-month term, unless terminated in accordance with the provisions of the Consulting Agreement, (ii)a $25,000 monthly consulting fee of which $15,000 is payable in cash and $10,000 is payable in restricted stock unit awards for the services specified in the applicable schedule to the Consulting Agreement, and (iii)termination by the Company or Mr. Feingold upon fifteen days’ written notice.

The above description of the terms of the Consulting Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of such agreement, a copy of which is filed as an exhibit to this Current Report on Form 8-K.

Item 5.02. Financial Statements and Exhibits.

(d) Exhibits

Exhibit

10.1 Consulting Agreement effective as of January15, 2018, by and between Presbia PLC and Vladimir Feingold.

Presbia PLC ExhibitEX-10.1 2 lens-ex101_7.htm EX-10.1 lens-ex101_7.htm Exhibit 10.1 Presbia Consulting Agreement THIS CONSULTING AGREEMENT (“Agreement”) is made effective as of January 15,…To view the full exhibit click here
About PRESBIA PLC (NASDAQ:LENS)
Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. The Company’s segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States. The Company’s lens, referred to as the microlens, is a miniature lens designed to be surgically implanted in a patient’s eye to improve that patient’s ability to see objects at close distances. The microlens is a disc shaped lens that has a refractive zone in the periphery designed to improve near vision problems associated with presbyopia and a central zone that is designed to improve distance vision. The Company’s solution is a standalone solution for plano presbyopes, or those individuals suffering from presbyopia but do not have any other visual disorders.